Concepts (115)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2025 | 480 | 2.640 |
Why?
|
| Pregnancy, Ectopic | 2 | 2024 | 23 | 1.500 |
Why?
|
| Metabolome | 6 | 2025 | 325 | 1.310 |
Why?
|
| Prenatal Diagnosis | 3 | 2025 | 626 | 0.930 |
Why?
|
| Fetal Blood | 2 | 2023 | 170 | 0.890 |
Why?
|
| Cyanosis | 1 | 2025 | 43 | 0.890 |
Why?
|
| Saliva | 1 | 2025 | 134 | 0.850 |
Why?
|
| Maternal Death | 1 | 2023 | 10 | 0.800 |
Why?
|
| Artificial Intelligence | 4 | 2025 | 298 | 0.770 |
Why?
|
| Biomarkers | 10 | 2024 | 3406 | 0.770 |
Why?
|
| Postpartum Hemorrhage | 1 | 2023 | 111 | 0.720 |
Why?
|
| Pre-Eclampsia | 5 | 2024 | 230 | 0.680 |
Why?
|
| Pregnancy | 16 | 2025 | 7543 | 0.600 |
Why?
|
| Heart Defects, Congenital | 3 | 2025 | 1861 | 0.520 |
Why?
|
| Case-Control Studies | 12 | 2024 | 3410 | 0.450 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2023 | 60 | 0.380 |
Why?
|
| ROC Curve | 6 | 2025 | 601 | 0.370 |
Why?
|
| Pregnancy Trimester, First | 3 | 2018 | 123 | 0.370 |
Why?
|
| Infant, Newborn | 11 | 2025 | 8542 | 0.320 |
Why?
|
| Magnetic Resonance Spectroscopy | 6 | 2024 | 297 | 0.310 |
Why?
|
| Tandem Mass Spectrometry | 4 | 2024 | 286 | 0.280 |
Why?
|
| Chromatography, Liquid | 3 | 2024 | 239 | 0.270 |
Why?
|
| Fetal Growth Retardation | 2 | 2020 | 254 | 0.260 |
Why?
|
| Female | 22 | 2025 | 70623 | 0.260 |
Why?
|
| Prospective Studies | 6 | 2024 | 6569 | 0.250 |
Why?
|
| Epigenesis, Genetic | 4 | 2023 | 754 | 0.250 |
Why?
|
| Fetus | 3 | 2025 | 585 | 0.240 |
Why?
|
| DNA Methylation | 5 | 2023 | 1122 | 0.240 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2023 | 20 | 0.210 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2023 | 16 | 0.200 |
Why?
|
| Obstetric Labor, Premature | 1 | 2023 | 84 | 0.200 |
Why?
|
| Humans | 26 | 2025 | 131985 | 0.200 |
Why?
|
| Neurofibromatosis 1 | 1 | 2023 | 66 | 0.190 |
Why?
|
| Maternal Mortality | 1 | 2023 | 81 | 0.190 |
Why?
|
| Adult | 9 | 2025 | 31547 | 0.190 |
Why?
|
| Tuberous Sclerosis | 1 | 2023 | 124 | 0.190 |
Why?
|
| Biomarkers, Tumor | 3 | 2023 | 1657 | 0.190 |
Why?
|
| Congenital Abnormalities | 1 | 2025 | 299 | 0.180 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2025 | 456 | 0.180 |
Why?
|
| Postpartum Period | 1 | 2023 | 231 | 0.180 |
Why?
|
| Prenatal Care | 1 | 2023 | 359 | 0.160 |
Why?
|
| Proton Magnetic Resonance Spectroscopy | 1 | 2019 | 30 | 0.160 |
Why?
|
| Turkey | 1 | 2019 | 67 | 0.160 |
Why?
|
| Premature Birth | 1 | 2023 | 418 | 0.150 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2018 | 57 | 0.140 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 2017 | 22 | 0.140 |
Why?
|
| Phosphatidylcholines | 1 | 2017 | 39 | 0.140 |
Why?
|
| Medulla Oblongata | 1 | 2017 | 22 | 0.130 |
Why?
|
| Pancreatic Neoplasms | 1 | 2023 | 728 | 0.130 |
Why?
|
| Birth Weight | 1 | 2019 | 350 | 0.130 |
Why?
|
| Stillbirth | 1 | 2018 | 103 | 0.130 |
Why?
|
| Sudden Infant Death | 1 | 2017 | 36 | 0.130 |
Why?
|
| Fetal Diseases | 1 | 2021 | 460 | 0.130 |
Why?
|
| Brain Concussion | 1 | 2019 | 238 | 0.130 |
Why?
|
| Isoleucine | 1 | 2016 | 27 | 0.130 |
Why?
|
| Endometrial Neoplasms | 1 | 2017 | 112 | 0.120 |
Why?
|
| Valine | 1 | 2016 | 111 | 0.120 |
Why?
|
| Leucine | 1 | 2016 | 260 | 0.120 |
Why?
|
| Placenta | 1 | 2020 | 538 | 0.120 |
Why?
|
| Alzheimer Disease | 1 | 2023 | 852 | 0.120 |
Why?
|
| Uterine Artery | 1 | 2015 | 29 | 0.110 |
Why?
|
| Fatty Acids | 1 | 2017 | 356 | 0.110 |
Why?
|
| Autism Spectrum Disorder | 1 | 2020 | 430 | 0.110 |
Why?
|
| Ovarian Neoplasms | 1 | 2018 | 462 | 0.110 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 414 | 0.100 |
Why?
|
| Proteomics | 1 | 2017 | 596 | 0.100 |
Why?
|
| Mass Spectrometry | 3 | 2019 | 356 | 0.100 |
Why?
|
| Aortic Valve Stenosis | 1 | 2016 | 377 | 0.090 |
Why?
|
| Algorithms | 2 | 2016 | 1721 | 0.090 |
Why?
|
| Brain | 1 | 2020 | 3175 | 0.070 |
Why?
|
| Pilot Projects | 2 | 2023 | 1441 | 0.060 |
Why?
|
| Michigan | 1 | 2023 | 50 | 0.050 |
Why?
|
| Cytosine | 1 | 2023 | 58 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 2140 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2023 | 115 | 0.050 |
Why?
|
| Immunoglobulin M | 1 | 2022 | 216 | 0.040 |
Why?
|
| Methionine | 1 | 2021 | 102 | 0.040 |
Why?
|
| Pregnancy Outcome | 1 | 2023 | 635 | 0.040 |
Why?
|
| Precision Medicine | 1 | 2023 | 360 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2022 | 433 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2019 | 34 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 2022 | 465 | 0.040 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 806 | 0.040 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2019 | 60 | 0.040 |
Why?
|
| Live Birth | 1 | 2018 | 72 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 9952 | 0.040 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2017 | 42 | 0.030 |
Why?
|
| Neoplasm Grading | 1 | 2018 | 301 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2017 | 69 | 0.030 |
Why?
|
| Lipids | 1 | 2021 | 561 | 0.030 |
Why?
|
| Autopsy | 1 | 2017 | 111 | 0.030 |
Why?
|
| Biological Assay | 1 | 2017 | 111 | 0.030 |
Why?
|
| Vaccination | 1 | 2022 | 1018 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2022 | 2674 | 0.030 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 1203 | 0.030 |
Why?
|
| Gene Ontology | 1 | 2015 | 55 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2016 | 198 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2018 | 822 | 0.030 |
Why?
|
| Pulsatile Flow | 1 | 2015 | 124 | 0.030 |
Why?
|
| CpG Islands | 1 | 2016 | 343 | 0.030 |
Why?
|
| Gestational Age | 1 | 2019 | 1224 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 321 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 2015 | 186 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1881 | 0.020 |
Why?
|
| Male | 4 | 2019 | 64910 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 1304 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 3011 | 0.020 |
Why?
|
| Prognosis | 1 | 2018 | 5008 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2023 | 17391 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 10941 | 0.010 |
Why?
|
| Infant | 1 | 2017 | 13047 | 0.010 |
Why?
|
| Adolescent | 1 | 2019 | 20535 | 0.010 |
Why?
|
| Aged | 1 | 2017 | 21415 | 0.010 |
Why?
|
| Child | 1 | 2019 | 25762 | 0.010 |
Why?
|
| Middle Aged | 1 | 2017 | 28976 | 0.010 |
Why?
|